A 100K well screen for a muscarinic receptor using the Epic® label-free system - a reflection on the benefits of the label-free approach to screening seven-transmembrane receptors

被引:36
作者
Dodgson, K. [1 ]
Gedge, L. [2 ]
Murray, D. C. [1 ]
Coldwell, M. [1 ]
机构
[1] AstraZeneca R&D Charnwood, Dept Biosci, Loughborough LE11 5RH, Leics, England
[2] Corning SAS, F-77211 Avon, France
关键词
Label-free; signaling; seven-transmembrane receptor; high throughput screening; PROTEIN-COUPLED RECEPTORS; DRUG DISCOVERY; BETA-ARRESTIN; ACTIVATION; BIOSENSOR; PATHWAYS; CELLS; GPCR;
D O I
10.1080/10799890903079844
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Seven-transmembrane receptors (7TMRs) are a family of proteins of great interest as therapeutic targets because of their abundance on the cell surface, diverse effects in modulating cell behavior and success as a key class of drugs. We have evaluated the Epic (R) label-free system for the purpose of identifying antagonists of the muscarinic M3 receptor. We compared the data generated from the label-free technology with data for the same compounds in a calcium flux assay. We have shown that this technology can be used for high throughput screening (HTS) of 7TMRs and as an orthogonal approach to enable rapid evaluation of HTS outputs. A number of compounds have been identified which were not found in a functional HTS measuring the output from a single pathway, which may offer new approaches to inhibiting responses through this receptor.
引用
收藏
页码:163 / 172
页数:10
相关论文
共 25 条
  • [1] Bender A, 2008, CURR OPIN DRUG DISC, V11, P327
  • [2] STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
    BLAND, JM
    ALTMAN, DG
    [J]. LANCET, 1986, 1 (8476) : 307 - 310
  • [3] Hit and lead generation:: Beyond high-throughput screening
    Bleicher, KH
    Böhm, HJ
    Müller, K
    Alanine, AI
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (05) : 369 - 378
  • [4] Can cell systems biology rescue drug discovery?
    Butcher, EC
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (06) : 461 - 467
  • [5] β-Arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2
    DeFea, KA
    Zalevsky, J
    Thoma, MS
    Déry, O
    Mullins, RD
    Bunnett, NW
    [J]. JOURNAL OF CELL BIOLOGY, 2000, 148 (06) : 1267 - 1281
  • [6] Drug discovery: A historical perspective
    Drews, J
    [J]. SCIENCE, 2000, 287 (5460) : 1960 - 1964
  • [7] Label-free cell-based assays for GPCR screening
    Fang, Ye
    Frutos, Anthony G.
    Verklereen, Ronald
    [J]. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2008, 11 (05) : 357 - 369
  • [8] Fang Ye, 2007, Journal of Pharmacological and Toxicological Methods, V55, P314, DOI 10.1016/j.vascn.2006.11.001
  • [9] Fang Y, 2006, BIOPHYS J, V91, P1925, DOI 10.1529/biophysj.105.007818
  • [10] Evaluation of dynamic mass redistribution technology for pharmacological studies of recombinant and endogenously expressed G protein-coupled receptors
    Lee, Paul H.
    Gao, Alice
    van Staden, Carlo
    Ly, Jenny
    Salon, John
    Xu, Arron
    Fang, Ye
    Verkleeren, Ron
    [J]. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2008, 6 (01) : 83 - 94